×
AbbVie Inventory 2012-2026 | ABBV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
AbbVie inventory for the quarter ending March 31, 2026 was
$4.938B
, a
10.97% increase
year-over-year.
AbbVie inventory for 2024 was
$4.181B
, a
2% increase
from 2023.
AbbVie inventory for 2023 was
$4.099B
, a
14.53% increase
from 2022.
AbbVie inventory for 2022 was
$3.579B
, a
14.42% increase
from 2021.
View More
AbbVie Inventory 2012-2026 | ABBV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
AbbVie inventory for 2024 was
$4.181B
, a
2% increase
from 2023.
AbbVie inventory for 2023 was
$4.099B
, a
14.53% increase
from 2022.
AbbVie inventory for 2022 was
$3.579B
, a
14.42% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$887.6B
Johnson & Johnson (JNJ)
$574.4B
Roche Holding AG (RHHBY)
$318.8B
Merck (MRK)
$299.9B
Novartis AG (NVS)
$294B
Novo Nordisk (NVO)
$167.5B
Pfizer (PFE)
$153.1B
Sanofi (SNY)
$114B
Bayer (BAYRY)
$46.2B
Innoviva (INVA)
$1.8B